参考文献/References:
[1]Zhou MG,Wang HD,Zeng XY,et al.Mortality, morbidity, and risk factors in China and its provinces, 1990-2017:a systematic analysis for the Global Burden of Disease Study 2017[J].Lancet,2019,394(10204):1145-1158.[2]Chen WQ,Zheng RS,Baade PD,et al.Cancer statistics in China, 2015[J].CA A Cancer J Clin,2016,66(2):115-132.[3]Anderson NM,SimonMC.The tumor microenvironment[J].Curr Biol,2020,30(16):R921-R925.[4]Li K,Liu CJ,Zhang XZ.Multifunctional peptides for tumor therapy[J].Adv Drug Deliv Rev,2020,160:36-51.[5]Zhang B,Lauschke VM.Genetic variability and population diversity of the human SLCO (OATP) transporter family[J].Pharmacol Res,2019,139:550-559.[6]R?觟sner J,Tietmeyer J,Merzendorfer H.Organic anion-transporting polypeptides are involved in the elimination of insecticides from the red flour beetle, Tribolium castaneum[J].J Pest Sci,2021,94(4):1427-1437.[7]Liu MY,Zhu DD,Wen JH,et al.Berberine promotes OATP1B1 expression and rosuvastatin uptake by inducing nuclear translocation of FXR and LXRα[J].Front Pharmacol,2020,11:375.[8]Tsuboyama T,Onishi H,Kim T,et al.Hepatocellular carcinoma: hepatocyte-selective enhancement at gadoxetic acid-enhanced MR imaging-correlation with expression of sinusoidal and canalicular transporters and bile accumulation[J].Radiology,2010,255(3):824-833.[9]Svoboda M,Wlcek K,Taferner B,et al.Expression of organic anion-transporting polypeptides 1B1 and 1B3 in ovarian cancer cells: relevance for paclitaxel transport[J].Biomed Pharmacother,2011,65(6):417-426.[10]Pressler H,Sissung TM,Venzon D,et al.Expression of OATP family members in hormone-related cancers: potential markers of progression[J].PLoS One,2011,6(5):e20372.[11]Lin T,Zhang E,Mai PP,et al.CXCL2/10/12/14 are prognostic biomarkers and correlated with immune infiltration in hepatocellular carcinoma[J].Biosci Rep,2021,41(6):BSR20204312.[12]Forner A,Reig M,Bruix J.Hepatocellular carcinoma[J].Lancet,2018,391(10127):1301-1314.[13]van de Steeg E,van Esch A,Wagenaar E,et al.Influence of human OATP1B1, OATP1B3, and OATP1A2 on the pharmacokinetics of methotrexate and paclitaxel in humanized transgenic mice[J].Clin Cancer Res,2013,19(4):821-832.[14]Zheng XL,Zhang JV,Bai YF,et al.Upregulation of OATP1A2 in human oesophageal squamous cell carcinoma cells via the HDAC6-GCN5/PCAF-H3K9Ac axis[J].Xenobiotica,2021,51(12):1453-1462.[15]Nakanishi T,Ohno Y,Aotani R,et al.A novel role for OATP2A1/SLCO2A1 in a murine model of colon cancer[J].Sci Rep,2017,7(1):16567.[16]Ueno A,Masugi Y,Yamazaki K,et al.OATP1B3 expression is strongly associated with Wnt/β-catenin signalling and represents the transporter of gadoxetic acid in hepatocellular carcinoma[J].J Hepatol,2014,61(5):1080-1087.[17]Zhou TF,Li SC,Xiang DM,et al.m6A RNA methylation-mediated HNF3γ reduction renders hepatocellular carcinoma dedifferentiation and sorafenib resistance[J].Signal Transduct Target Ther,2020,5(1):296.[18]Wen JH,Zhao MH.OATP1B1 plays an important role in the transport and treatment efficacy of sorafenib in hepatocellular carcinoma[J].Dis Markers,2021,2021:9711179.[19]Wu ZH,Yang DL,Wang L,et al.Epigenetic and immune-cell infiltration changes in the tumor microenvironment in hepatocellular carcinoma[J].Front Immunol,2021,12:793343.[20]Guo FF,Cui JW.The role of tumor-infiltrating B cells in tumor immunity[J].J Oncol,2019,2019:2592419.[21]Indino S,Borzi C,Moscheni C,et al.The educational program of macrophages toward a hyperprogressive disease-related phenotype is orchestrated by tumor-derived extracellular vesicles[J].Int J Mol Sci,2022,23(24):15802.[22]Eum HH,Kwon M,Ryu D,et al.Tumor-promoting macrophages prevail in malignant ascites of advanced gastric cancer[J].Exp Mol Med,2020,52(12):1976-1988.[23]Bahig H,Taussky D,Delouya G,et al.Neutrophil count is associated with survival in localized prostate cancer[J].BMC Cancer,2015,15:594.[24]Li MO,Wolf N,Raulet DH,et al.Innate immune cells in the tumor microenvironment[J].Cancer Cell,2021,39(6):725-729.[25]Hadrup S,Donia M,Thor Straten P.Effector CD4 and CD8 T cells and their role in the tumor microenvironment[J].Cancer Microenviron,2013,6(2):123-133.[26]Guo YY,Yang J,Ren KD,et al.The heterogeneity of immune cell infiltration landscape and its immunotherapeutic implications in hepatocellular carcinoma[J].Front Immunol,2022,13:861525.[27]Ma XZ,Bi EG,Lu Y,et al.Cholesterol induces CD8+T cell exhaustion in the tumor microenvironment[J].Cell Metab,2019,30(1):143-156.e5.
相似文献/References:
[1]王利娜,赵雪梅,徐云霞,等.磁共振扩散张量成像在肝细胞癌及
肝转移瘤鉴别诊断价值研究[J].医学信息,2018,31(09):12.[doi:10.3969/j.issn.1006-1959.2018.09.004]
WANG Li-na,ZHAO Xue-mei,XU Yun-xia,et al.Diagnostic Value of Magnetic Resonance Diffusion Tensor Imaging in Hepatocellular Carcinoma and Liver Metastases[J].Journal of Medical Information,2018,31(02):12.[doi:10.3969/j.issn.1006-1959.2018.09.004]
[2]刘 冰,杨 帅,费锡斌,等.GPC-3联合CK-19免疫组化检测在肝细胞癌诊断及鉴别诊断中的应用[J].医学信息,2019,32(23):169.[doi:10.3969/j.issn.1006-1959.2019.23.054]
LIU Bing,YANG Shuai,FEI Xi-bin,et al.Application of GPC-3 Combined with CK-19 Immunohistochemical Detection in Diagnosis and Differential Diagnosis of Hepatocellular Carcinoma[J].Journal of Medical Information,2019,32(02):169.[doi:10.3969/j.issn.1006-1959.2019.23.054]
[3]李文华,许传斌,崔景景,等.基于治疗前MR-T2WI影像组学特征预测肝细胞癌射频消融术后早期复发的价值[J].医学信息,2022,35(18):39.[doi:10.3969/j.issn.1006-1959.2022.18.009]
LI Wen-hua,XU Chuan-bin,CUI Jing-jing,et al.The Value of Predicting Early Recurrence of Hepatocellular Carcinoma After Radiofrequency Ablation Based on Pre-treatment MR-T2WI Radiomics Features[J].Journal of Medical Information,2022,35(02):39.[doi:10.3969/j.issn.1006-1959.2022.18.009]
[4]彭莉蓉,黎村艳,史 杨.肿瘤微环境免疫细胞中差异lncRNA对肝细胞癌预后的预测价值[J].医学信息,2022,35(20):18.[doi:10.3969/j.issn.1006-1959.2022.20.005]
PENG Li-rong,LI Cun-yan,SHI Yang.The Predictive Value of Differential lncRNA in Tumor Microenvironment Immune Cells for the Prognosis of Hepatocellular Carcinoma[J].Journal of Medical Information,2022,35(02):18.[doi:10.3969/j.issn.1006-1959.2022.20.005]
[5]刘丽丽.CLCVP对肝细胞癌行腹腔镜肝叶切除手术相关指标及肝门阻断时间的影响[J].医学信息,2020,33(19):88.[doi:10.3969/j.issn.1006-1959.2020.19.025]
LIU Li-li.The Effect of CLCVP on the Operation-related Indexes and Port Occlusion Time in Patients with Hepatocellular Carcinoma Undergoing Laparoscopic Lobectomy[J].Journal of Medical Information,2020,33(02):88.[doi:10.3969/j.issn.1006-1959.2020.19.025]
[6]裴金仙,陈天狮,任巧晶,等.JAK2/STAT3通路在HBV相关肝细胞癌中表达及机制研究[J].医学信息,2022,35(24):59.[doi:10.3969/j.issn.1006-1959.2022.24.012]
PEI Jin-xian,CHEN Tian-shi,REN Qiao-jing,et al.The Expression and Mechanism of JAK2/STAT3 Pathway in HBV-related Hepatocellular Carcinoma[J].Journal of Medical Information,2022,35(02):59.[doi:10.3969/j.issn.1006-1959.2022.24.012]
[7]杨孟涛,汪 艇,杜 伟,等.miR-181b-5p靶向调控SPP1在肝细胞癌中过表达的临床意义及作用机制[J].医学信息,2022,35(24):79.[doi:10.3969/j.issn.1006-1959.2022.24.016]
YANG Meng-tao,WANG Ting,DU Wei,et al.Clinical Significance and Mechanism of miR-181b-5p Targeting to Regulate SPP1 Overexpression in Hepatocellular Carcinoma[J].Journal of Medical Information,2022,35(02):79.[doi:10.3969/j.issn.1006-1959.2022.24.016]
[8]孙莹莹,龚先琼.中药单体治疗肝细胞癌的研究[J].医学信息,2021,34(09):33.[doi:10.3969/j.issn.1006-1959.2021.09.008]
SUN Ying-ying,GONG Xian-qiong.Study on the Treatment of Hepatocellular Carcinoma with Chinese Medicine Monomer[J].Journal of Medical Information,2021,34(02):33.[doi:10.3969/j.issn.1006-1959.2021.09.008]
[9]蒙建源,朱刚健.应用细胞免疫治疗肝细胞癌的研究[J].医学信息,2023,36(05):177.[doi:10.3969/j.issn.1006-1959.2023.05.037]
MENG Jian-yuan,ZHU Gang-jian.Study on Cellular Immunotherapy for Hepatocellular Carcinoma[J].Journal of Medical Information,2023,36(02):177.[doi:10.3969/j.issn.1006-1959.2023.05.037]
[10]张 政,卢鸿健,李明慧,等.基于生物信息学分析肝细胞癌中lncRNA-miRNA-mRNA的调控网络[J].医学信息,2023,36(06):1.[doi:10.3969/j.issn.1006-1959.2023.06.001]
ZHANG Zheng,LU Hong-jian,LI Ming-hui,et al.Analysis of lncRNA-miRNA-mRNA Regulatory Network in Hepatocellular Carcinoma Based on Bioinformatics[J].Journal of Medical Information,2023,36(02):1.[doi:10.3969/j.issn.1006-1959.2023.06.001]